Dual spatial maps of transcript and protein abundance in the mouse brain

Integrating quantitative proteomic and transcriptomic datasets promises valuable insights in unraveling the molecular mechanisms of the brain. We concentrate on recent studies using mass spectrometry and microarray data to investigate transcript and protein abundance in normal and diseased neural tissues. Highlighted are dual spatial maps of these molecules obtained using voxelation of the mouse brain. We demonstrate that the relationship between transcript and protein levels displays a specific anatomical distribution, with greatest fidelity in midline structures and the hypothalamus. Genes are also identified that have strong correlations between mRNA and protein abundance. In addition, transcriptomic and proteomic analysis of mouse models of Parkinson’s disease are discussed.

[1]  Joachim Klose,et al.  An approach to handling and interpretation of ambiguous data in transcriptome and proteome comparisons , 2008, Proteomics.

[2]  R. Vossen,et al.  Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms , 2008, Nucleic acids research.

[3]  Vladislav A Petyuk,et al.  A genome-scale map of expression for a mouse brain section obtained using voxelation. , 2007, Physiological genomics.

[4]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[5]  Richard D. Smith,et al.  High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry , 2004, Expert review of proteomics.

[6]  P. Kebarle,et al.  Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the titration method , 2004, Journal of the American Society for Mass Spectrometry.

[7]  W. Schubert,et al.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.

[8]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[9]  Richard D. Smith,et al.  Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. , 2008, Journal of proteome research.

[10]  Ronald J Moore,et al.  Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry , 2005, Proteomics.

[11]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[12]  Neil L Kelleher,et al.  Detection and localization of protein modifications by high resolution tandem mass spectrometry. , 2005, Mass spectrometry reviews.

[13]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[14]  Vladislav A Petyuk,et al.  Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry. , 2007, Genome research.

[15]  Christian Stephan,et al.  Interlocking transcriptomics, proteomics and toponomics technologies for brain tissue analysis in murine hippocampus , 2008, Proteomics.

[16]  Shiaoching Gong,et al.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes , 2003, Nature.

[17]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[18]  E. Hall,et al.  Treatment of mice with methamphetamine produces cell loss in the substantia nigra , 1996, Brain Research.